GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (LSE:OVB) » Definitions » 10-Year ROIIC %

Ovoca Bio (LSE:OVB) 10-Year ROIIC % : 0.27% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Ovoca Bio 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Ovoca Bio's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was 0.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Ovoca Bio's 10-Year ROIIC % or its related term are showing as below:

LSE:OVB's 10-Year ROIIC % is ranked better than
65.33% of 1275 companies
in the Biotechnology industry
Industry Median: -33.25 vs LSE:OVB: 0.27

Ovoca Bio 10-Year ROIIC % Historical Data

The historical data trend for Ovoca Bio's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio 10-Year ROIIC % Chart

Ovoca Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.04 -2.19 11.46 7.24 0.27

Ovoca Bio Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 7.24 - 0.27 -

Competitive Comparison of Ovoca Bio's 10-Year ROIIC %

For the Biotechnology subindustry, Ovoca Bio's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovoca Bio's 10-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ovoca Bio's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Ovoca Bio's 10-Year ROIIC % falls into.



Ovoca Bio 10-Year ROIIC % Calculation

Ovoca Bio's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -1.608 (Dec. 2023) - -1.524 (Dec. 2013) )/( 0.574 (Dec. 2023) - 13.52 (Dec. 2013) )
=-0.084/-12.946
=0.65%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Ovoca Bio  (LSE:OVB) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Ovoca Bio 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovoca Bio Business Description

Traded in Other Exchanges
Address
17 Pembroke Street Upper, Dublin, IRL, D02 AT22
Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio Headlines

From GuruFocus

Overlay Shares Core Bond ETF Crosses $100 Million in Assets

By PRNewswire PRNewswire 07-09-2020

Overlay Shares Cross $500 Million in Assets

By PRNewswire PRNewswire 02-01-2022

Top 5 2nd Quarter Trades of Advocacy Wealth Management Services, LLC

By GuruFocus Research GuruFocus Editor 07-06-2022

Overlay Shares Reach 5-Year Track Record

By PRNewswire 10-03-2024

Overlay Shares Launch New ETFs and Cross $300 Million in Assets

By PRNewswire PRNewswire 01-21-2021